ask="20.80"
ask_size="300"
average_daily_volume="201258"
bid="17.65"
bid_size="2100"
book_value="7.04"
change="+0.10"
change_from_200_day_moving_average="4.45"
change_from_50_day_moving_average="0.92"
change_from_52_week_high="-4.89"
change_From_52_week_low="8.25"
change_in_percent="+0.49%"
close="20.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-79.91M"
eps_estimate_current_year="-3.17"
eps_estimate_next_quarter="-0.92"
eps_estimate_next_year="-3.33"
ex_dividend_date="N/A"
float_shares="18669000"
high="21.05"
high_52_weeks="25.49"
last_trade_date="1/18/2017"
last_trade_price="20.60"
last_trade_size="6900"
last_trade_time="4:00pm"
low="20.20"
low_52_weeks="12.35"
market_capitalization="587.41M"
moving_average_200_day="16.15"
moving_average_50_day="19.68"
name="Revance Therapeutics
Inc."
notes="N/A"
one_year_target_price="36.60"
open="20.55"
pe_ratio="N/A"
peg_ratio="-0.60"
percent_change_from_200_day_moving_average="+27.57%"
percent_change_from_50_day_moving_average="+4.69%"
percent_change_from_52_week_high="-19.18%"
percent_change_from_52_week_low="+66.80%"
previous_close="20.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.91"
price_per_sales="1948.53"
revenue="300000.00"
shares_outstanding="28515000"
short_ratio="22.54"
stock_exchange="NGM"
symbol="RVNC"
volume="167519"
weeks_range_52="12.35 - 25.49"
